Human amniotic membrane-derived mesenchymal stem cell conditioned medium
Human amniotic membrane-derived mesenchymal stem cell conditioned medium has been studied in 1 paper since 2025: none in people yet, 1 in animals. The research so far is in animals. The newest paper, May 29, 2025: “Therapeutic Potential of Human Amniotic Membrane-Derived Mesenchymal Stem Cell Conditioned Medium in Combating Oxidative Stress and Age-Related Female Infertility”.
1 paper studies it2 findingsUpdated
- 1 lab in 1 country
- Funders: National Research Foundation and 2 more
- Animals1
What did studies of Human amniotic membrane-derived mesenchymal stem cell conditioned medium find?
2Studies of Human amniotic membrane-derived mesenchymal stem cell conditioned medium measured 2 outcomes; the most studied are reproductive hormones (1 study) and oxidative stress and ROS signaling (1).
Reproductive hormones
upin mice1
1 study
Reproductive hormones
upin mice1
Human amniotic membrane-derived mesenchymal stem cell conditioned medium improves reproductive hormones in mice.
“Human AMSC-CM positively regulated age-dependent changes in reproductive hormones, comparable to those observed in younger mice.”
Animalsconditioned mediumfemales
Cells
Oxidative stress and ROS signaling
downin mice1
1 study
Oxidative stress and ROS signaling
downin mice1
Human amniotic membrane-derived mesenchymal stem cell conditioned medium decreases oxidative stress and ROS signaling in mice.
“Antioxidative effects of human AMSC-CM were found in the reproductive organs of aged mice at both the RNA and protein levels.”
Animalsconditioned mediumreproductive organsfemales
Cells